Clover Health Investments Research and Development Expenses 2020-2024 | CLOV

Clover Health Investments research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Clover Health Investments Annual Research and Development Expenses
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
Clover Health Investments Quarterly Research and Development Expenses
(Millions of US $)
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.428B $2.034B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.763B 20.73
Inspire Medical Systems (INSP) United States $5.181B 0.00
Axonics (AXNX) United States $3.439B 0.00
10x Genomics (TXG) United States $3.145B 0.00
IRhythm Technologies (IRTC) United States $3.107B 0.00
Azenta (AZTA) United States $2.928B 159.12
Olink Holding AB (publ) (OLK) Sweden $2.910B 0.00
Enovis (ENOV) United States $2.800B 20.75
Hims & Hers Health (HIMS) United States $2.768B 0.00
Privia Health (PRVA) United States $2.139B 120.20
Schrodinger (SDGR) United States $1.673B 0.00
Omnicell (OMCL) United States $1.389B 48.02
Phreesia (PHR) United States $1.238B 0.00
Standard BioTools (LAB) United States $0.699B 0.00
Fulgent Genetics (FLGT) United States $0.652B 0.00
Definitive Healthcare (DH) United States $0.610B 0.00
Talkspace (TALK) United States $0.483B 0.00
Health Catalyst (HCAT) United States $0.394B 0.00
Pulmonx (LUNG) United States $0.340B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.314B 0.00
P3 Health Partners (PIII) United States $0.231B 0.00
Butterfly Network (BFLY) United States $0.205B 0.00
Outset Medical (OM) United States $0.169B 0.00
American Well (AMWL) United States $0.152B 0.00
TruBridge (TBRG) United States $0.123B 5.26
Augmedix (AUGX) United States $0.122B 0.00
MSP Recovery (LIFW) United States $0.120B 0.00
111 (YI) China $0.095B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.073B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.060B 0.00
Zepp Health (ZEPP) China $0.054B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
EUDA Health Holdings (EUDA) Singapore $0.046B 0.00
Movano (MOVE) United States $0.039B 0.00
Akili (AKLI) United States $0.035B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
CareCloud (CCLD) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Biotricity (BTCY) United States $0.011B 0.00
Syra Health (SYRA) United States $0.009B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00